Shingles vaccine study for healthy adults
Treatments studied
Part of Infections clinical trials.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years of age or older.
- You have never had shingles before.
- You have never received a chickenpox or shingles vaccine.
- You are generally healthy and do not have a serious illness.
- You are not pregnant or planning to become pregnant in the next 6 months, and you agree to use birth control.
- You have not taken certain medications or received other vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine (LYB004) in adults 40 and older. It looks at how safe the vaccine is and how well it helps your body build protection against shingles.
This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
Hear when a new Herpes Zoster (HZ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.